HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clinique Chief Daniel Brestle named Estee Lauder president, CEO U.S. & Canada.

This article was originally published in The Rose Sheet

Executive Summary

LAUDER's NEW U.S./CANADA PRESIDENT, CEO IS CLINIQUE's BRESTLE, who succeeds Robin Burns following the announcement of her plans to depart for The Limited, Inc. July 1, Estee Lauder announced June 22. Daniel Brestle advances from his position as president Clinique USA & Canada, which he has held since 1992. With 25 years of experience in the industry, Brestle is one of Lauder's "most experienced, broad-gauged managers who has developed Clinique into one of [the company's] largest profit contributors," the firm said.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005549

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel